BriaCell Prices $15 Mln Public Offering To Fund Operations And Growth Initiatives
16/7 03:38
(RTTNews) - BriaCell Therapeutics Corp. (BCTX), a clinical-stage biotech company focused on cancer immunotherapies, has priced a best-efforts public offering of 12 million units at $1.25 per unit, aiming to raise $15 million in gross proceeds....